Delphia (Usa) Inc. Danaher Corp Transaction History

Delphia (Usa) Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$224.99 - $256.14 $248,163 - $282,522	-1,103 Reduced 45.96%	1,297 $311,000
Q1 2023 May 15, 2023	BUY	$239.75 - $277.0 $144,809 - $167,308	604 Added 33.63%	2,400 $604,000
Q4 2022 Feb 14, 2023	SELL	$241.42 - $282.29 $58,423 - $68,314	-242 Reduced 11.87%	1,796 $476,000
Q3 2022 Nov 14, 2022	SELL	$247.06 - $1507.4 $262,377 - $1.6 Million	-1,062 Reduced 34.26%	2,038 $526,000
Q2 2022 Aug 15, 2022	BUY	$237.11 - $299.66 $111,915 - $141,439	472 Added 17.96%	3,100 $786,000
Q1 2022 May 16, 2022	BUY	$257.27 - $315.76 $101,878 - $125,040	396 Added 17.74%	2,628 $771,000
Q4 2021 Feb 14, 2022	BUY	$292.08 - $329.01 $651,922 - $734,350	2,232 New	2,232 $734,000

2,432

563M

3.94M

4.11M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $177B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Delphia (Usa) Inc., based on Form 13F filings with the SEC.

Stay updated on Delphia (Usa) Inc. with notifications on news.